Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager

NCT07094048 is registered in ClinicalTrials.gov with CHU de Quebec-Universite Laval as lead sponsor.

NCT NCT07094048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07094048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunoglobulins in Multiple Myeloma Patients Receiving a BCMA-Directed T Cell Engager
Lead sponsor
CHU de Quebec-Universite Laval
Phase
Phase 4
Overall status
Recruiting
Start date
January 5, 2026
Completion date
December 31, 2029
Enrollment
80 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

multiple myeloma refractory, relapsed multiple myeloma